Nano-X Imaging (NNOX) Competitors $5.04 -0.12 (-2.33%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$5.03 -0.01 (-0.28%) As of 06/13/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NNOX vs. AORT, PLSE, BLFS, ESTA, FNA, KMTS, MDXG, INMD, SSII, and BBNXShould you be buying Nano-X Imaging stock or one of its competitors? The main competitors of Nano-X Imaging include Artivion (AORT), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Establishment Labs (ESTA), Paragon 28 (FNA), Kestra Medical Technologies (KMTS), MiMedx Group (MDXG), InMode (INMD), SS Innovations International (SSII), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry. Nano-X Imaging vs. Its Competitors Artivion Pulse Biosciences BioLife Solutions Establishment Labs Paragon 28 Kestra Medical Technologies MiMedx Group InMode SS Innovations International Beta Bionics Artivion (NYSE:AORT) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, community ranking, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Do institutionals and insiders hold more shares of AORT or NNOX? 86.4% of Artivion shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 7.6% of Artivion shares are owned by company insiders. Comparatively, 7.7% of Nano-X Imaging shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community believe in AORT or NNOX? Nano-X Imaging received 7 more outperform votes than Artivion when rated by MarketBeat users. However, 83.33% of users gave Artivion an outperform vote while only 75.51% of users gave Nano-X Imaging an outperform vote. CompanyUnderperformOutperformArtivionOutperform Votes3083.33% Underperform Votes616.67%Nano-X ImagingOutperform Votes3775.51% Underperform Votes1224.49% Does the media favor AORT or NNOX? In the previous week, Nano-X Imaging had 4 more articles in the media than Artivion. MarketBeat recorded 6 mentions for Nano-X Imaging and 2 mentions for Artivion. Artivion's average media sentiment score of 1.55 beat Nano-X Imaging's score of 0.91 indicating that Artivion is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artivion 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Nano-X Imaging 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer AORT or NNOX? Artivion presently has a consensus price target of $31.40, indicating a potential upside of 11.31%. Nano-X Imaging has a consensus price target of $9.50, indicating a potential upside of 88.49%. Given Nano-X Imaging's higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than Artivion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Artivion 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is AORT or NNOX more profitable? Artivion has a net margin of -0.22% compared to Nano-X Imaging's net margin of -465.38%. Artivion's return on equity of 5.15% beat Nano-X Imaging's return on equity.Company Net Margins Return on Equity Return on Assets Artivion-0.22% 5.15% 1.91% Nano-X Imaging -465.38%-27.63%-24.72% Which has better earnings and valuation, AORT or NNOX? Artivion has higher revenue and earnings than Nano-X Imaging. Artivion is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArtivion$390.08M3.09-$30.69M-$0.50-56.42Nano-X Imaging$11.55M25.22-$60.78M-$0.90-5.60 Which has more volatility and risk, AORT or NNOX? Artivion has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 1.99, meaning that its stock price is 99% more volatile than the S&P 500. SummaryArtivion beats Nano-X Imaging on 12 of the 19 factors compared between the two stocks. Get Nano-X Imaging News Delivered to You Automatically Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNOX vs. The Competition Export to ExcelMetricNano-X ImagingX IndustryBusiness SectorNASDAQ ExchangeMarket Cap$291.21M$11.62B$14.17B$8.51BDividend YieldN/A1.72%2.58%4.16%P/E Ratio-5.9318.5633.2919.65Price / Sales25.227.66315.07152.18Price / CashN/A11.9030.9334.64Price / Book1.422.065.334.59Net Income-$60.78M$344.53M$194.83M$248.14M7 Day Performance-8.86%-4.07%-2.31%-1.03%1 Month Performance-10.16%-3.66%0.02%3.42%1 Year Performance-33.77%4.39%24.05%13.80% Nano-X Imaging Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNOXNano-X Imaging1.9472 of 5 stars$5.04-2.3%$9.50+88.5%-37.3%$291.21M$11.55M-5.93190Analyst RevisionAORTArtivion3.5049 of 5 stars$29.20+0.9%$31.40+7.5%+21.1%$1.25B$390.08M-1,460.001,300Positive NewsShort Interest ↓PLSEPulse Biosciences1.346 of 5 stars$17.29+1.1%N/A+29.3%$1.16B$700K0.00140BLFSBioLife Solutions2.0798 of 5 stars$23.84+0.5%$31.17+30.7%+7.3%$1.13B$87.76M-22.49440Trending NewsInsider TradeGap UpESTAEstablishment Labs2.6769 of 5 stars$38.49+1.3%$52.40+36.1%-16.3%$1.11B$170.24M-14.92960News CoverageAnalyst ForecastFNAParagon 28N/A$13.11+0.1%$12.75-2.7%+104.9%$1.10B$256.18M-17.71343,000High Trading VolumeKMTSKestra Medical TechnologiesN/A$21.17+2.3%$27.50+29.9%N/A$1.09B$52.64M0.00300News CoverageMDXGMiMedx Group3.7767 of 5 stars$6.45-0.6%$12.50+93.8%-12.6%$952.68M$352.38M11.73870Positive NewsAnalyst RevisionINMDInMode3.6778 of 5 stars$14.56+2.8%$18.54+27.3%-26.6%$920.32M$392.41M6.20480Positive NewsSSIISS Innovations InternationalN/A$4.58-23.7%N/AN/A$886.71M$22.13M0.004Positive NewsHigh Trading VolumeBBNXBeta BionicsN/A$19.41+1.7%$23.13+19.1%N/A$841.54M$69.83M0.00294News CoverageAnalyst Forecast Related Companies and Tools Related Companies Artivion Competitors Pulse Biosciences Competitors BioLife Solutions Competitors Establishment Labs Competitors Paragon 28 Competitors Kestra Medical Technologies Competitors MiMedx Group Competitors InMode Competitors SS Innovations International Competitors Beta Bionics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NNOX) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nano-X Imaging Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nano-X Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.